US marketing to get tough for Ranbaxy Laboratories

4th Annual India Leadership Conclave & Business Leadership Awards 2013 CEO of The Year Nominees in Close Competition as 5 Nominees Receive Overseas Votes Mumbai, Maharashtra, India, Thursday, 9th May 2013: With the judgment date nearing to 42 days ...

Arun Nanda, Chairman, MHRIL said, "As India's largest vacation ownership company, we remain committed to growth. This year we have taken the bold and confident step of making additions internationally with two large resorts in Dubai and Bangkok." ...

Three ships of the Indian Navy's First Training Squadron, commanded by Senior Officer Capt. Vinay Kumar Sawhney and comprising INS Sujata, INS Tarangini and ICGS Varuna, visited Colombo recently in continuation of the training interaction between ...

BOSTON--A subsidiary of India's largest pharmaceutical company has reached an agreement with federal prosecutors to pay a record $500 million in fines for selling adulterated drugs. On Monday, the U.S. Justice Department announced the plea deal with ...

Text size Print Forward By Zachary Brennan , 15-May-2013 Related tags: Adulterated drugs, , Ranbaxy, Consent decree, India Related topics: , In the largest US generic drug safety settlement ever, Ranbaxy USA has agreed to pay $500m after pleading ...

The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans. FORTUNE -- On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss ...

In an affirmative sign, Ranbaxy shrugged off early losses after Monday's ruling to steadily climb 1.75 percent to Rs 463.45 on Wednesday on the Bombay Stock Exchange after analysts said the settlement of the US lawsuit clears a big overhang on the ...

Credits: specialtyformulations.com Top News newsletter E-mail * do not change Contact Email Contact Email2 Contact Url Subscribe to Blog Remember my Info Ranbaxy USA, Inc. has agreed to plead guilty to criminal information charging violations of the ...

Ranbaxy Laboratories Ltd. (RBXY) may resume exports of drugs from two plants in India after resolving U.S. criminal charges that it sold adulterated medication, said analysts including Ranjit Kapadia at Centrum Broking Pvt. India's largest drugmaker ...